A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 3, 2007, Pages 385-389

  Hreybe, Haitham ^a   Saba, Samir ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Defibrillator; Risk score; Therapy

Indexed keywords

ADULT; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEFIBRILLATOR; FEMALE; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROPORTIONAL HAZARDS MODEL; QRS COMPLEX; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT INDICATION;

ARRHYTHMIA; CREATINE; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PENNSYLVANIA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33947240892     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00679.x     Document Type: Article

References (17)

1. Zipes DP, Wyse DG, Friedman PL, Epstein AE, Hallstrom AP, Greene HL, Schron EP,, et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337:1576-1783.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101:1297-1302.
3. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102:748-754.
4. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000; 342:1937-1945.
5. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335:1933-1940.
6. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Sudden Cardiac Death in Heart Failure Trial (SCDHeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
8. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapywith or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350:2140-2150.
9. Valenti R, Schlapfer J, Fromer M, Fischer A, Kappenberger L. Impact of the implantable cardioverter-defibrillator on rehospitalizations. Eur Heart J 1996; 17:1565-1571.
10. Carroll DL, Hamilton GA. Quality of life in implanted cardioverter defibrillator recipients: The impact of a device shock. Heart Lung 2005; 34:169-178.
11. Prudente LA. Psychological disturbances, adjustment, and the development of phantom shocks in patients with an implantable cardioverter defibrillator. J Cardiovasc Nurs 2005; 20:288-293.
12. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace 2003; 5:381-389.
13. Wu C, Hannan EL, Walford G, Ambrose JA, Holmes DR Jr, King SB III, Clark LT, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol 2006; 47:654-660.
14. Vyas AK, Moss AJ, Zareba W, Hall W, McNitt S. Risk stratification of madit-II patients for predicting mortality and ICD benefit. Circulation 2004; 110:III-503.
15. Hreybe H, Bedi M, Ezzeddine R, Barrington W, Jain S, Ngwu O, Saba S. Indications for internal cardioverter defibrillator implantation predict time to first shock and the modulating effect of beta-blockers. Am Heart J 2005; 150:1064.
16. Hreybe H, Ezzeddine R, Bedi M, Barrington W, Bazaz R, Ganz L, Jain S, et al. Renal insufficiency predicts the time to first appropriate defibrillator shock. Am Heart J 2005 2006; 151:852-856.
17. Bollmann A, Husser D, Cannom DS. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Am J Cardiovasc Drugs 2005; 5:371-378.